Código QR (código de barras bidimensional)

Propagermanium administration for patients with type 2 diabetes and nephropathy: A randomized pilot trial

Summary Aims We assessed the potential efficacy and safety of propagermanium (PG), an organic compound that inhibits the C–C chemokine receptor type 2, administration in patients with type 2 diabetes and nephropathy. Furthermore, we assessed the feasibility of future studies. Materials and methods W...

Fuld beskrivelse

Na minha lista:
Principais autores: Akinori Hara, Miho Shimizu, Erika Hamaguchi, Hirokazu Kakuda, Kenzo Ikeda, Toshiya Okumura, Kiyoki Kitagawa, Yoshitaka Koshino, Motoo Kobayashi, Kazuya Takasawa, Yukimasa Hisada, Tadashi Toyama, Yasunori Iwata, Norihiko Sakai, Takashi Wada
Format: Artigo
Sprog:Inglês
Udgivet: Wiley 2020-07-01
Serier:Endocrinology, Diabetes & Metabolism
Fag:
albuminuria
CCR2
diabetes
kidney
MCP‐1
propagermanium
Online adgang:https://doi.org/10.1002/edm2.159
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker